Results 1 to 10 of about 11,910 (159)
Leptomeningeal carcinomatosis of gastric adenocarcinoma
The Turkish Journal of Gastroenterology, 2011 Gastric cancer is the third most common malignancy among gastrointestinal malignancies. With the advance of new treatments, overall survival in gastric cancer is extending, and metastasis to atypical sites is seen more commonly. Leptomeningeal metastasis is one such atypical metastasis for gastric cancer. We report a case of gastric adenocarcinoma with
Gülcan BULUT +3 more
doaj +5 more sources
Multiple Dural Tuberculomas Presenting as Leptomeningeal Carcinomatosis [PDF]
Case Reports in Neurological Medicine, 2011 Objective and Importance. We present the rare occurrence of multiple dural-based tuberculomas mimicking leptomeningeal carcinomatosis in a young immunocompetent patient. Clinical Presentation.
Hasan Kocaeli +4 more
doaj +6 more sources
Leptomeningeal Carcinomatosis with Delayed Ocular Manifestations [PDF]
Case Reports in Oncology, 2021 The most common presenting symptoms of leptomeningeal carcinomatosis (LC) are ocular manifestations with vision loss. There are multiple reports of undiagnosed LC causing sudden, complete, monocular vision loss as the presenting symptom; however, sudden ...
Craig Czyz, Kyle Blair, Reece Bergstrom
doaj +3 more sources
Life, 2023 Leptomeningeal carcinomatosis is a rare but serious consequence of pre-existing tumors, such as breast, lung, and gastrointestinal carcinomas. Further, leptomeningeal carcinomatosis is more frequently diagnosed with breast cancers, if only because breast
Francesca Zacchi +3 more
doaj +1 more source
Radiology Case Reports, 2022 Since leptomeningeal carcinomatosis is rarely observed before diagnosis of the primary cancer, its detection is often delayed. We report the case of a 60-year-old woman who presented with lung adenocarcinoma with leptomeningeal carcinomatosis.
Hajime Yokota +7 more
doaj +1 more source
Thoracic Cancer, 2021 Dacomitinib, a second‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitor, is a standard therapeutic option for patients with EGFR‐mutant non‐small cell lung cancer (NSCLC).
Shun Mizusaki +5 more
doaj +1 more source
Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab [PDF]
Encephalitis, 2023 When a patient with encephalopathy has an organic brain lesion, his symptom is easily and often mistakenly attributed to that brain lesion. However, a combination of different conditions is also possible.
Seolah Lee +3 more
doaj +1 more source
Case Reports in Oncology, 2020 Leptomeningeal carcinomatosis accounts for only 4% of cases of multiple cranial neuropathies. Here, we report the case of a patient who presented with multiple synchronous cranial neuropathies.
Bailey Gleason Fitzgerald +4 more
doaj +1 more source
Leptomeningeal Metastasis Mimicking a Subacute Epidural Hematoma: Case Report
Clinical Medicine Insights: Case Reports, 2022 Leptomeningeal carcinomatosis is extremely rare in colorectal adenocarcinoma, its incidence is far less than 1%. The neurological symptoms are pleomorphic.
Lahfidi Amal +5 more
doaj +1 more source
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
Nature Communications, 2021 Leptomeningeal metastases from solid tumors are a rare complication with a very poor prognosis. Here the authors report the efficacy and safety of combined ipilimumab and nivolumab in patients with leptomeningeal carcinomatosis.
Priscilla K. Brastianos +29 more
doaj +1 more source